Eco R1 Capital, LLC Atreca, Inc. Transaction History

Eco R1 Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.56 - $3.25 $559,696 - $1.17 Million	-358,780 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.61 - $5.2 $577,635 - $1.87 Million	358,780 New	358,780 $1.14 Million
Q3 2021 Nov 15, 2021	SELL	$4.91 - $9.07 $11.9 Million - $22 Million	-2,426,685 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$12.67 - $23.19 $11.9 Million - $21.7 Million	937,500 Added 62.95%	2,426,685 $33.9 Million
Q2 2020 Aug 14, 2020	BUY	$12.52 - $23.45 $4.8 Million - $8.98 Million	383,005 Added 34.62%	1,489,185 $31.7 Million
Q1 2020 May 15, 2020	SELL	$11.4 - $27.28 $4.28 Million - $10.2 Million	-375,231 Reduced 25.33%	1,106,180 $18.3 Million
Q3 2019 Nov 14, 2019	SELL	$10.42 - $22.04 $58,018 - $122,718	-5,568 Reduced 0.37%	1,481,411 $18.1 Million
Q2 2019 Aug 14, 2019	BUY	$17.07 - $18.84 $25.4 Million - $28 Million	1,486,979 New	1,486,979 $28 Million

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.